Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Targeting the TLR co-receptor CD14 with TLR2-derived peptides modulates immune responses to pathogens.

Raby AC, Holst B, Le Bouder E, Diaz C, Ferran E, Conraux L, Guillemot JC, Coles B, Kift-Morgan A, Colmont CS, Szakmany T, Ferrara P, Hall JE, Topley N, Labéta MO.

Sci Transl Med. 2013 May 15;5(185):185ra64. doi: 10.1126/scitranslmed.3005544.

2.

Critical role for the kinesin KIF3A in the HIV life cycle in primary human macrophages.

Gaudin R, de Alencar BC, Jouve M, Bèrre S, Le Bouder E, Schindler M, Varthaman A, Gobert FX, Benaroch P.

J Cell Biol. 2012 Oct 29;199(3):467-79. doi: 10.1083/jcb.201201144. Epub 2012 Oct 22.

3.

Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering.

Raby AC, Le Bouder E, Colmont C, Davies J, Richards P, Coles B, George CH, Jones SA, Brennan P, Topley N, Labéta MO.

J Immunol. 2009 Jul 1;183(1):506-17. doi: 10.4049/jimmunol.0802909.

4.

In vitro identification of two adherence factors required for in vivo virulence of Pseudomonas fluorescens.

de Lima Pimenta A, Di Martino P, Le Bouder E, Hulen C, Blight MA.

Microbes Infect. 2003 Nov;5(13):1177-87.

PMID:
14623013

Supplemental Content

Loading ...
Support Center